NLM Digital Collections

Search

Start Over Authors Lin, Grace A., author ✖Remove constraint Authors: Lin, Grace A., author

1. Tirzepatide for type 2 diabetes: final report

Author(s):
Lin, Grace A., author
Nikitin, Dmitriy, author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jon D., author
Brouwer, Elizabeth, author
Chen, Yilin, MPH, author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 15, 2022
Subject(s):
Diabetes Mellitus, Type 2 -- drug therapy
Gastric Inhibitory Polypeptide -- therapeutic use
Hypoglycemic Agents -- therapeutic use
Incretins -- therapeutic use
United States

2. Aducanumab for Alzheimer’s disease: effectiveness and value

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States

3. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

Author(s):
Lin, Grace A., author
Jih, Jane, author
Agboola, Foluso, author
Peason, Steven D., author
Kazi, Dhruv S., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):
Anticholesteremic Agents -- therapeutic use
Atherosclerosis -- prevention & control
ATP Citrate (pro-S)-Lyase -- antagonists & inhibitors
Dicarboxylic Acids -- therapeutic use
Fatty Acids
Hyperlipoproteinemia Type II -- drug therapy
RNA, Small Interfering
Secondary Prevention
Treatment Outcome
Drug Therapy Combination
Ezetimibe -- therapeutic use
United States

4. Lecanemab for early Alzheimer’s disease: final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Agboola, Foluso, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David, (Of Institute for Clinical and Economic Review), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 17, 2023
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal, Humanized
United States

5. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Nikitin, Dmitriy, author
Agboola, Foluso, author
McKenna, Avery, author
Herron-Smith, Serina, author
Pearson, Steven D, author
Campbell, Jonathan D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 21, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Treatment Outcome
Administration, Oral
United States

6. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

Author(s):
Beaudoin, Francesca L., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Yeung, Kai, 1981- author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David M., author
Lin, Grace A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of School of Pharmacy, University of Colorado), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 23, 2023
Subject(s):
Cost-Effectiveness Analysis
Heterocyclic Compounds, 2-Ring
Hot Flashes
Menopause
Thiadiazoles
Vasomotor System
United States